FDA
approval
· 2021-05-21
FDA Approved: KETOCONAZOLE — Original Application (Xiromed, LLC)
Summary
FDA has approved Xiromed, LLC's original generic application for Ketoconazole Foam, a topical antifungal 2% product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for KETOCONAZOLE (KETOCONAZOLE FOAM)